Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 109.48%51M | -301.50%-538M | -68.06%267M | 377.71%836M | -86.54%175M | -41.26%1.3B | 26.17%2.21B | 41.45%1.75B | -28.90%1.24B | 17.76%1.74B |
Net profit before non-cash adjustment | 79.88%-335M | -66.67%-1.67B | -212.25%-999M | 8.67%890M | 2,097.56%819M | -103.79%-41M | 0.19%1.08B | 26.17%1.08B | -30.24%856M | 76.55%1.23B |
Total adjustment of non-cash items | -25.64%609M | -22.15%819M | 1,131.37%1.05B | -128.02%-102M | -72.36%364M | 163.93%1.32B | -1.38%499M | -42.70%506M | 150.85%883M | -46.34%352M |
-Depreciation and amortization | -3.62%612M | -3.05%635M | 0.00%655M | 7.38%655M | -2.40%610M | -2.80%625M | -1.83%643M | 3.15%655M | 6.72%635M | 8.58%595M |
-Reversal of impairment losses recognized in profit and loss | --12M | --0 | 33.33%384M | --288M | ---- | --720M | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 95.76%-49M |
-Share of associates | -72.99%-301M | -70.59%-174M | -25.93%-102M | 48.73%-81M | -125.71%-158M | 66.35%-70M | 19.69%-208M | -68.18%-259M | 6.67%-154M | 31.54%-165M |
-Disposal profit | -12.50%42M | 4,700.00%48M | 100.10%1M | -1,613.56%-1.01B | -2,066.67%-59M | -62.50%3M | 180.00%8M | -104.13%-10M | 303.36%242M | -151.52%-119M |
-Net exchange gains and losses | ---- | ---- | ---- | ---- | ---- | 166.67%2M | -102.40%-3M | 26.26%125M | --99M | --0 |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -20.97%49M | --62M |
-Other non-cash items | -21.29%244M | 171.93%310M | 142.55%114M | 262.07%47M | -178.38%-29M | -37.29%37M | 1,280.00%59M | -141.67%-5M | -57.14%12M | -97.75%28M |
Changes in working capital | -172.08%-222M | 43.93%308M | 365.22%214M | 104.57%46M | -4,473.91%-1.01B | -96.37%23M | 281.33%633M | 133.27%166M | -402.42%-499M | 26.92%165M |
-Change in receivables | -137.89%-147M | 832.08%388M | -114.29%-53M | -55.89%371M | 804.30%841M | 111.51%93M | -251.03%-808M | 64.62%535M | 32.65%325M | 337.50%245M |
-Change in inventory | 147.06%80M | 43.52%-170M | -784.09%-301M | 126.83%44M | -9.33%-164M | -42.86%-150M | -161.05%-105M | 1,046.67%172M | 114.71%15M | -175.56%-102M |
-Change in payables | -15.34%287M | 2.11%339M | 180.39%332M | 76.60%-413M | -3,360.78%-1.77B | -103.61%-51M | 323.77%1.41B | 19.41%-631M | -660.19%-783M | -128.89%-103M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -144.80%-56M | 881.25%125M |
-Provision for loans, leases and other losses | -77.51%-442M | -205.51%-249M | 436.36%236M | -46.34%44M | -37.40%82M | -2.24%131M | 13,300.00%134M | --1M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --89M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -158.82%-44M | -142.86%-17M | 12.50%-7M | 11.11%-8M | -12.50%-9M | 0.00%-8M | 20.00%-8M | 28.57%-10M | 26.32%-14M | 24.00%-19M |
Interest received (cash flow from operating activities) | 27.37%121M | 9.20%95M | -13.00%87M | -6.54%100M | -5.31%107M | 29.89%113M | -71.66%87M | 93.08%307M | 87.06%159M | 117.95%85M |
Tax refund paid | -1.35%-75M | 62.05%-74M | 14.85%-195M | 9.13%-229M | 24.32%-252M | 9.02%-333M | -16.93%-366M | 23.66%-313M | -66.67%-410M | 24.54%-246M |
Other operating cash inflow (outflow) | 0 | 0.00%-2M | -100.00%-2M | -200.00%-1M | 1M | 0 | 0 | -1M | 0 | 0 |
Operating cash flow | 109.89%53M | -457.33%-536M | -78.51%150M | 3,072.73%698M | -97.95%22M | -44.34%1.07B | 10.88%1.93B | 78.15%1.74B | -37.66%975M | 39.15%1.56B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -100.68%-295M | 83.46%-147M | -149.83%-889M | 367.07%1.78B | -65.35%-668M | 31.76%-404M | -28.98%-592M | -44.34%-459M | 43.11%-318M | 30.13%-559M |
Net intangibles purchase and sale | -916.67%-61M | 91.67%-6M | -2.86%-72M | 1.41%-70M | 21.98%-71M | -59.65%-91M | -375.00%-57M | 62.50%-12M | -39.13%-32M | -21.05%-23M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---33M | ---- | ---- |
Net investment product transactions | --0 | 822.22%83M | --9M | --0 | --85M | --0 | --0 | --0 | --0 | --0 |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.88%-1M | -61.88%-811M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%1M | -98.00%1M |
Net changes in other investments | 181.40%35M | -59.26%-43M | 61.43%-27M | -1,500.00%-70M | 141.67%5M | -340.00%-12M | 183.33%5M | -100.00%-6M | -111.11%-3M | 268.75%27M |
Investing cash flow | -184.07%-321M | 88.46%-113M | -159.55%-979M | 353.31%1.64B | -28.01%-649M | 21.27%-507M | -26.27%-644M | -44.48%-510M | 74.14%-353M | 16.97%-1.37B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -129.32%-732M | 557.11%2.5B | 119.14%380M | -531.52%-1.99B | 3,385.71%460M | 97.90%-14M | 4.99%-667M | 0.85%-702M | -398.73%-708M | -80.93%237M |
Net common stock issuance | --0 | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 |
Cash dividends paid | ---- | 50.00%-77M | 0.00%-154M | 0.00%-154M | 0.00%-154M | 0.00%-154M | 0.00%-154M | 0.00%-154M | 0.00%-154M | 0.00%-154M |
Cash dividends for minorities | 0.00%-28M | 0.00%-28M | 0.00%-28M | -16.67%-28M | 0.00%-24M | 0.00%-24M | 4.00%-24M | 24.24%-25M | -13.79%-33M | -38.10%-29M |
Net other fund-raising expenses | 50.00%-1M | 0.00%-2M | -100.00%-2M | 50.00%-1M | ---2M | ---- | ---- | 0.00%-1M | 50.00%-1M | -100.00%-2M |
Financing cash flow | -131.84%-761M | 1,119.39%2.39B | 109.04%196M | -874.29%-2.17B | 245.83%280M | 77.28%-192M | 4.20%-845M | 1.56%-882M | -1,823.08%-896M | -95.13%52M |
Net cash flow | ||||||||||
Beginning cash position | 65.36%4.44B | -18.64%2.69B | 5.36%3.3B | -9.92%3.13B | 11.26%3.48B | 16.08%3.13B | 14.70%2.69B | 4.22%2.35B | 11.26%2.25B | 45.09%2.02B |
Current changes in cash | -159.10%-1.03B | 375.04%1.74B | -463.79%-633M | 150.14%174M | -193.03%-347M | -14.65%373M | 26.67%437M | 225.91%345M | -209.16%-274M | -54.11%251M |
Effect of exchange rate changes | 23.08%16M | -23.53%13M | 440.00%17M | ---5M | --0 | -533.33%-19M | ---3M | --0 | ---11M | --0 |
Cash adjustments other than cash changes | 0.00%1M | 0.00%1M | 200.00%1M | -150.00%-1M | 200.00%2M | -100.00%-2M | ---1M | ---- | 1,752.17%380M | -128.05%-23M |
End cash Position | -22.79%3.43B | 65.36%4.44B | -18.64%2.69B | 5.36%3.3B | -9.92%3.13B | 11.26%3.48B | 16.08%3.13B | 14.70%2.69B | 4.22%2.35B | 11.26%2.25B |
Free cash flow | 66.63%-343M | -26.76%-1.03B | -2,352.78%-811M | 105.02%36M | -224.26%-717M | -54.82%577M | 1.27%1.28B | 148.23%1.26B | -48.27%508M | 411.46%982M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |